Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-05-27FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Carbamazepine submitted by Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2010-05-27Clinical Trial Update: Use of the Atkins Diet for Children With Sturge Weber Syndrome [Phase 1]
A Phase 1 clinical trial evaluated the Atkins diet as a dietary intervention for epilepsy in children with Sturge-Weber syndrome; the study …
-
CLINICAL_TRIALS trial_result · 2010-05-25Clinical Trial Update: A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures [Phase 1]
Completed Phase 1 study assessing pharmacokinetics, safety and tolerability of topiramate in infants aged 1-24 months with refractory partia…
-
CLINICAL_TRIALS trial_result · 2010-05-24Clinical Trial Update: The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin [Phase 3]
Phase 3 clinical trial update for NPC-06 evaluating the safety, efficacy, and pharmacokinetics of fosphenytoin in epilepsy has completed.
-
FDA approval · 2010-05-20FDA Approved: PRIMIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Primidone submitted by Amneal Pharmaceuticals LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-05-20FDA Approved: PRIMIDONE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Primidone (Actavis Pharma, Inc.) under the ANDA pathway, indicating an approved modification…
-
FDA approval · 2010-05-20FDA Approved: PRIMIDONE — Supplemental Application (Oxford Pharmaceuticals, LLC)
The FDA approved a supplemental application for Primidone by Oxford Pharmaceuticals, LLC under an ANDA for this generic antiseizure medicati…
-
FDA approval · 2010-05-20FDA Approved: PRIMIDONE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for PRIMIDONE from Lannett Company, Inc., a generic antiseizure medication. The action is linked to …
-
CLINICAL_TRIALS research · 2010-05-19Clinical Trial Update: Study of Verapamil in Refractory Epilepsy [NA]
This is a clinical trial update about using verapamil for refractory epilepsy; no phase information or trial status is provided.
-
CLINICAL_TRIALS trial_result · 2010-05-18Clinical Trial Update: Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures [Phase 3]
A Phase 3 study evaluating Lamictal Extended-Release as add-on therapy for primary generalized tonic-clonic seizures has completed and resul…
-
FDA approval · 2010-05-17FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for gabapentin filed by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients [Phase 4]
Phase 4 clinical trial comparing best medical practice with or without vagus nerve stimulation in pharmacoresistant partial epilepsy; the st…
-
FDA label_change · 2010-05-14FDA Approved: LAMOTRIGINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for lamotrigine from Sun Pharmaceutical Industries, resulting in labeling changes for the drug.
-
FDA approval · 2010-05-14FDA Approved: GABAPENTIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Gabapentin from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2010-05-13FDA Approved: GABAPENTIN — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for gabapentin from Actavis Pharma, Inc. under ANDA075350, typically reflecting a label change or fo…
-
FDA approval · 2010-05-13FDA Approved: GABAPENTIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA granted supplemental approval for gabapentin submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2010-04-29FDA Approved: OXCARBAZEPINE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for oxcarbazepine (ANDA077747) from Advagen Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients [Phase 3]
A Phase 3 pilot trial evaluating metabolism and weight changes in epilepsy patients treated with topiramate has completed.
-
CLINICAL_TRIALS safety_alert · 2010-04-27Clinical Trial Update: A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures
This clinical trial update reports on the safety of topiramate when given in combination with other medications in adults and children with …
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy
This is an observational safety study evaluating topiramate in adults and children with epilepsy, reporting safety outcomes from a completed…
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: A Study of the Prevalence of Headache in Epileptic Patients
A completed clinical trial studying the prevalence of headache among patients with epilepsy.
-
FDA approval · 2010-04-26FDA Approved: LEVETIRACETAM — Supplemental Application (Bionpharma Inc.)
The FDA approved a supplemental application for a generic levetiracetam product from Bionpharma Inc., allowing its marketing in the United S…
-
CLINICAL_TRIALS trial_result · 2010-04-23Clinical Trial Update: A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy [Phase 1]
Phase 1 study analyzes pharmacokinetics and safety of intravenous carbamazepine relative to oral carbamazepine in adults with epilepsy. The …
-
FDA approval · 2010-04-20FDA Approved: VIMPAT — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for VIMPAT (lacosamide) submitted by UCB, Inc.
-
FDA approval · 2010-04-19FDA Approved: ZONEGRAN — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for ZONEGRAN (zonisamide) submitted by Advanz Pharma (US) Corp.